Condition of newborns of mothers with convulsions, mother being treated with a medication, magnesium sulphate

Not Applicable

Completed

Conditions: Health Condition 1: null- Neonates of Eclamptic mothers

Registration Number: CTRI/2014/08/004892

Lead Sponsor: BURDWAN MEDICAL COLLEGE BURDWA

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 100

Inclusion Criteria

1. Eclampsia was diagnosed if there was h/o generalized tonic clonic convulsions with or without elevated blood pressure and proteinuria (by dipstick method) in the absence of any underlying seizure disorders after 20 wks of gestational age.

2. All cases of antepartum, intrapartum eclampsia, presenting in obstetric emergency, labour rooms and/or wards who gave informed consent to participate in the study were included in the study.

3. Neonates (of eclamptic mothers), of gestational age > 28 wks, were included in the study.

Exclusion Criteria

Eclampsia patients who had renal failure, severe pulmonary oedema with respiratory failure, having received magnesium sulphate and/or other anticonvulsant before coming to our hospital, cerebrovascular accident and Disseminated Intravascular Coagulation (DIC) were excluded from the from the present study. Neonates (of eclamptic mothers), of gestational age < 28 wks were excluded from the present study.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of neonatal outcome in terms of Apgar score(5min), time to first stool ( or 24 hrs), time to first void ( or 48 hrs) , admission to NICU, no. of episodes of feeding intolerance (3 or 3), %age of neonates with respiratory depression, %age of neonates with hypotonia.Timepoint: Early neonatal period

Secondary Outcome Measures